Camps J, Joven J, Mackness B, Mackness MI, Tawfik DS, Draganov DI, Costa LG, Paragh G, Seres I, Horke S, James RW, Hernandez AF, Reddy ST, Shih DM, Navab M, Rochu D, Aviram M (2011)
Paraoxonase-1 and clopidogrel efficacy
Nat Med 17: 1041

Teiber JF, Draganov DI (2011)
High-performance liquid chromatography analysis of N-acyl homoserine lactone hydrolysis by paraoxonases
Methods Mol Biol 692: 291

Draganov DI (2010)
Lactonases with oragnophosphatase activity: Structural and evolutionary perspectives
Chemico-Biological Interactions 187: 370

Draganov DI, Teiber JF, Watson C, Bisgaier C, Nemzek J, Remick D, Standiford T, La Du BN (2010)
PON1 and oxidative stress in human sepsis and an animal model of sepsis
Advances in Experimental Medicine & Biology 660: 89

Connelly PW, Maguire GF, Picardo CM, Teiber JF, Draganov DI (2008)
Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma
J Lipid Res 49: 245

Teiber JF, Horke S, Haines DC, Chowdhary PK, Xiao J, Kramer GL, Haley RW, Draganov DI (2008)
Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone
Infect Immun 76: 2512

Teiber JF, Billecke SS, La Du BN, Draganov DI (2007)
Estrogen esters as substrates for human paraoxonases
Archives of Biochemistry & Biophysics 461: 24

Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN (2005)
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
J Lipid Res 46: 1239

Teiber JF, Draganov DI, La Du BN (2004)
Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH
J Lipid Res 45: 2260

Rosenblat M, Draganov DI, Watson CE, Bisgaier CL, La Du BN, Aviram M (2003)
Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress
Arterioscler Thromb Vasc Biol 23: 468

Teiber JF, Draganov DI, La Du BN (2003)
Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3
Biochemical Pharmacology 66: 887

Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov DI, Rosenblat M (2000)
Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities
Circulation 101: 2510